Elevating Biotech Investor Relations
At Ascend IR, we specialize in strategic investor relations and corporate communications tailored for emerging biotech companies. We help companies craft compelling investment narratives, engage with institutional investors, and position them for long-term market success.
Investor Relations Strategy & Execution
Custom IR strategies
Targeted investor outreach
Earnings and event preparation
Compelling Storytelling & Corporate Messaging
Clear, investor-friendly narratives
Consistent messaging across all communications
Strategic positioning to differentiate your company
Materials Preparation
Professional investor decks, earnings presentations, and fact sheets
Press releases and financial reports
Quarterly earnings support, including script & Q&A
Capital Markets & Analyst Engagement
Investor/Sell-side analyst targeting and outreach
NDRs and broker conference support
Market intelligence and investor feedback
Thought Leadership & Market Positioning
Enhancing executive visibility
Positioning your company as a leader in its therapeutic space
Leveraging data-driven insights to strengthen investor perception and long-term valuation
Crisis & Special Situations Communications
Strategic guidance for high-impact announcements, including clinical data, regulatory updates, and corporate developments
Crisis management support
Reputation management
Your Trusted IR Partner
At Ascend IR, we empower biotech innovators to build investor confidence and achieve sustainable growth through dedicated partnership and strategic engagement.
150+
15
Trusted by Innovators
Proven Success